2018 Medicinal Chemistry Reviews
Recent Progress in Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors for the Treatment of Parkinson's Disease
Douglas S. Williamson, Morten Jørgensen and Kenneth V. Christensen
Ref. n°: REV2018-ch5
You must be connected to be able to download the pdf file of this chapter.